Infliximab biosimilar CT-P13 for inflammatory bowel disease.

Infliximab biosimilar CT-P13 for inflammatory bowel disease.

Lancet Gastroenterol Hepatol. 2018 Mar 29;:

Authors: Bonovas S, Peyrin-Biroulet L, Danese S

PMID: 29606565 [PubMed – as supplied by publisher]

PubMed Link: https://www.ncbi.nlm.nih.gov/pubmed/29606565?dopt=Abstract